Poster Poster Program Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Retrospective Study of Lung Shunt Fraction Using Data Acquired from 3D SPECT and 2D Planar Imaging

Abstract
Purpose

A modified lung shunt fraction (LSF) based on conventional 2D planar imaging data was proposed. That modified LSF can reduce the 2D overestimation errors and get closer results with 3D SPECT images.

Methods

3D LSF from attenuation corrected SPECT images is treated as gold standard method, a modified LSF based on 2D planar imaging data was derived. The modified LSF includes both attenuation and scatter correction, through introducing a correction factor k, which is a planar imaging system and patient dependent factor. Factor k was in the range of 0.35~0.5 for typical clinical settings.

Results

The test results show that 1) the average difference between 2D LSF and 3D LSF was 3.0% across all patients, while the average difference between the modified LSF and 3D LSF was only 1.2%; 2) For cases where with 2D LSF>5%, the average difference between 2D LSF and 3D LSF was 6.6%, while the average difference between the modified LSF and 3D LSF is only 1.6%;3) For cases where with 2D LSF>10%, the average difference between 2D LSF and 3D LSF was 10.1%, while the average difference between the modified LSF and 3D LSF is only 1.9%. The results indicate that using the modified LSF instead of 2D LSF can reduce the overestimation errors, especially in cases with higher lung shunt fractions.

Conclusion

We proposed a method for determining the corrected LSF based on 2D planar images, which we call the modified LSF. Test results show that using the modified LSF can reduce overestimation errors and yield results closer to those obtained from 3D SPECT/CT images, which we consider the gold standard method, especially in cases with a high lung shunt fraction, where the overestimation error is significantly reduced.

People

Related

Similar sessions

Poster Poster Program
Jul 19 · 07:00
Adverse Events in Targeted Radionuclide Therapy

Radiopharmaceutical therapy (RPT) plays an important role in the management of oncology patients, particularly those with thyroid cancer, prostate cancer, and neuroendocrine tumor. The use of radionuclide therapy has expanded rap...

Harrison L. Agordzo
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Development of a Web-Based Theranostic Workflow Management Tool

To develop a Web-Based Theranostic Workflow Management Tool (TWMT) to efficiently manage Theranostic program in the department of radiation oncology (RadOnc).

Ling Zhuang, PhD
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Epidseg-Net:the Multi-Modal Fusion Framework Based on Drr Guidance In Radiotherapy Is Used for Precise Segmentation of Epid Lung Targets

The proposed multimodal segmentation framework, named EPIDSeg-Net, comprises an encoder, a multi-scale feature layer, and a decoder. The encoder utilizes a dual-branch architecture: a CNN branch for extracting local texture featu...

Huang Qian Qianjia, M.Eng
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Voxel-Wise Dose Heterogeneity Following Yttrium-90 Glass Microsphere Radioembolization In HCC: Association with Pretreatment Tc-99m Maa SPECT/CT Tumor-to-Normal Ratio

Tumor-to-normal ratio (TNR) derived from pretreatment Tc-99m MAA SPECT/CT is widely used as a surrogate marker of perfusion in yttrium-90 (⁹⁰Y) radioembolization for patients with hepatocellular carcinoma (HCC). Delivered activit...

Xinyi Li
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested